Hims & Hers Health will buy Eucalyptus, an Australian digital health company, in a deal valued at $1.15 billion.
Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new ...
By Christy Santhosh Feb 19 (Reuters) - Hims & Hers Health said on Thursday it will acquire Australian digital health company ...
Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with stakeholders across the industry." ...
StockStory.org on MSN
What to expect from Hims & Hers Health’s (HIMS) Q4 earnings
Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market close. Here’s ...
Consumer health and wellness platform Hims & Hers will ramp up its international presence with the acquisition of Australian ...
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...
Hims & Hers is facing battles on multiple fronts as it seeks to maintain its lucrative business in copycat weight loss drugs.
Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally.
Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims ...
Hims & Hers (HIMS) stock rises after-hours as the company announces a $1.15B deal to acquire Australia's Eucalyptus, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results